信号转导与靶向治疗（英文）（Signal Transduction and Targeted Therapy）杂志栏目及论文类型发文方向

/有基金 100.0%

信号转导与靶向治疗（英文）（Signal Transduction and Targeted Therapy）杂志征稿要求

1、投稿方式：在线投稿。

2、刊内网址（202404期）：

http://www.nature.com/sigtrans/

3、投稿系统：https://mts-sigtrans.nature.com/

4、官网邮箱：sttt@scu.edu.cn

5、官网电话：028-85421753

6、微信公众号：Sigtrans

2024年7月10日星期三

《信号转导与靶向治疗（英文版）》作者指南

【官网信息】

Guide for Authors

Aims and Scope

Signal Transduction and Targeted Therapy is an international, peer-reviewed, open-access journal that publishes original research articles and review articles related to all aspects of signal transduction in physiological and pathological processes, as well as signal transduction-targeted therapeutics in the form of biological agents and small molecular drugs used to treat human diseases such as cancer, cardiovascular diseases, autoimmune diseases, nervous system diseases, and others. This journal focuses on cutting-edge advances both experimentally and clinically.

Journal Details

Editors-in-Chief:

Carlo M. Croce

Institute of Genetics, The Ohio State University, USA

Kang Zhang

Institute for Genomic Medicine, University of California San Diego, USA

Yu-Quan Wei

State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, China

Editorial office:

Address: No. 17, Section 3, Renmin South Road, Chengdu, Sichuan, 610041, China

Tel: 86-28-85421753 Fax: 86-28-85164060

E-mail: sttt@scu.edu.cn

ARTICLE TYPES

……

作者指南更多详情：

https://www.nature.com/documents/sigtrans-gta.pdf